Theresa Baker
About Theresa Baker
Theresa Baker is a Scientist I at MOMA Therapeutics, specializing in early discovery oncology and immune-oncology. She has extensive experience in optimizing assays for molecular and cellular research and has worked at several pharmaceutical companies throughout her career.
Current Role at MOMA Therapeutics
Theresa Baker serves as Scientist I at MOMA Therapeutics, a position she has held since 2020. Located in Cambridge, Massachusetts, she focuses on research initiatives that align with the company's mission in therapeutic development. Her role involves applying her expertise in molecular and cellular research to contribute to ongoing projects.
Previous Experience in Pharmaceutical Research
Theresa Baker has extensive experience in the pharmaceutical industry. She worked at EMD Serono as a Temp from 2006 to 2007, followed by a Research Assistant position at Acceleron Pharma from 2007 to 2010. She then joined Aileron Therapeutics as a Senior Research Assistant from 2010 to 2012, before returning to ARIAD Pharmaceuticals, Inc. where she held the roles of Associate Scientist from 2012 to 2015 and Senior Associate Scientist from 2015 to 2016.
Education and Qualifications
Theresa Baker obtained her Bachelor's degree from Northeastern University, where she studied from 2005 to 2009. Prior to that, she completed an Associate's degree at Vermont Technical College from 2003 to 2005. Her educational background provides a solid foundation for her career in scientific research.
Specialization in Oncology Research
Theresa Baker specializes in early discovery oncology and immune-oncology fields. Her expertise includes optimizing assays for molecular and cellular research, which is critical in advancing cancer research and therapeutic development.
Laboratory Skills and Proficiencies
Theresa Baker is highly proficient in the upkeep and optimization of laboratory equipment. Her skills ensure that laboratory operations run smoothly, which is essential for maintaining the integrity of research processes.